Contraindication to sitagliptin or metformin or thiazolidinedione
Pregnant or breast feeding women
Type 1 diabetes, gestational diabetes, or secondary forms of diabetes
Not appropriate for oral antidiabetic agent
Medication which affect glycemic control
Disease which affect efficacy and safety of drugs
Any major illness (Liver disease, Renal failure, Heart disease, Cancer, etc)

NCT02315287_exc_T1
Drug
sitagliptin
NCT02315287_exc_T2
Drug
metformin
NCT02315287_exc_T3
Drug
thiazolidinedione
NCT02315287_exc_T4
Condition
Contraindication
NCT02315287_exc_T5
Scope
sitagliptin or metformin or thiazolidinedione
NCT02315287_exc_T6
Condition
Pregnant
NCT02315287_exc_T7
Condition
breast
NCT02315287_exc_T8
Condition
Type 1 diabetes
NCT02315287_exc_T9
Condition
gestational diabetes
NCT02315287_exc_T10
Condition
secondary forms of diabetes
NCT02315287_exc_T11
Negation
Not
NCT02315287_exc_T12
Observation
appropriate
NCT02315287_exc_T13
Drug
oral antidiabetic agent
NCT02315287_exc_T14
Drug
Medication
NCT02315287_exc_T15
Observation
affect glycemic control
NCT02315287_exc_T16
Drug
Disease
NCT02315287_exc_T17
Qualifier
affect efficacy
NCT02315287_exc_T18
Qualifier
safety of drugs
NCT02315287_exc_T19
Scope
affect efficacy and safety of drugs
NCT02315287_exc_T20
Condition
major illness
NCT02315287_exc_T21
Condition
Liver disease
NCT02315287_exc_T22
Condition
Renal failure
NCT02315287_exc_T23
Condition
Heart disease
NCT02315287_exc_T24
Condition
Cancer
NCT02315287_exc_T25
Scope
Liver disease, Renal failure, Heart disease, Cancer